Market Challenges | Explore Avantor's navigation through sector headwinds, balancing strong Labs performance against Biopro division struggles in a competitive landscape |
Leadership Transition | Delve into the implications of CEO Michael Stubblefield's departure and its potential impact on Avantor's strategic direction and market positioning |
Financial Resilience | Discover Avantor's financial health with a $8.74B market cap, P/E ratio of 12.61, and strong gross margins of 33.25%, despite recent market challenges |
Future Prospects | Analyst targets range from $13 to $31, reflecting diverse views on Avantor's recovery potential and long-term growth in the life sciences industry |
Metrics to compare | AVTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVTRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.7x | −0.4x | −0.4x | |
PEG Ratio | 0.07 | 0.01 | 0.00 | |
Price/Book | 1.3x | 0.8x | 2.6x | |
Price / LTM Sales | 1.1x | 1.9x | 3.0x | |
Upside (Analyst Target) | −10.7% | 124.6% | 56.2% | |
Fair Value Upside | Unlock | 16.2% | 8.9% | Unlock |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.